SCH 900237/MK-8237
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SCH 900237/MK-8237, covering 2017-03-03 to 2017-03-03. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P05607) [Phase 3]